These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 8202521

  • 1. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells.
    Corvi R, Amler LC, Savelyeva L, Gehring M, Schwab M.
    Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5523-7. PubMed ID: 8202521
    [Abstract] [Full Text] [Related]

  • 2. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line.
    Corvi R, Savelyeva L, Amler L, Handgretinger R, Schwab M.
    Eur J Cancer; 1995 Jun 07; 31A(4):520-3. PubMed ID: 7576957
    [Abstract] [Full Text] [Related]

  • 3. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
    Corvi R, Savelyeva L, Schwab M.
    Cancer Res; 1995 Aug 15; 55(16):3471-4. PubMed ID: 7627947
    [Abstract] [Full Text] [Related]

  • 4. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
    Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J, Oren M, Amler L, Schwab M.
    Oncogene; 1995 Mar 16; 10(6):1081-6. PubMed ID: 7700632
    [Abstract] [Full Text] [Related]

  • 5. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N.
    Genes Chromosomes Cancer; 2001 Jan 16; 30(1):87-90. PubMed ID: 11107180
    [Abstract] [Full Text] [Related]

  • 6. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC, Schürmann J, Schwab M.
    Genes Chromosomes Cancer; 1996 Feb 16; 15(2):134-7. PubMed ID: 8834178
    [Abstract] [Full Text] [Related]

  • 7. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization.
    McRobert TL, Rudduck C, Kees UR, Garson OM.
    Cancer Genet Cytogenet; 1992 Apr 16; 59(2):128-34. PubMed ID: 1581879
    [Abstract] [Full Text] [Related]

  • 8. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
    Pandita A, Godbout R, Zielenska M, Thorner P, Bayani J, Squire JA.
    Genes Chromosomes Cancer; 1997 Nov 16; 20(3):243-52. PubMed ID: 9365831
    [Abstract] [Full Text] [Related]

  • 9. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.
    Stock C, Bozsaky E, Watzinger F, Poetschger U, Orel L, Lion T, Kowalska A, Ambros PF.
    Am J Pathol; 2008 Jan 16; 172(1):203-14. PubMed ID: 18165268
    [Abstract] [Full Text] [Related]

  • 10. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F.
    Cytogenet Genome Res; 2004 Jan 16; 106(1):49-54. PubMed ID: 15218241
    [Abstract] [Full Text] [Related]

  • 11. MYCN gene amplification. Identification of cell populations containing double minutes and homogeneously staining regions in neuroblastoma tumors.
    Yoshimoto M, Caminada De Toledo SR, Monteiro Caran EM, de Seixas MT, de Martino Lee ML, de Campos Vieira Abib S, Vianna SM, Schettini ST, Anderson Duffles Andrade J.
    Am J Pathol; 1999 Nov 16; 155(5):1439-43. PubMed ID: 10550298
    [Abstract] [Full Text] [Related]

  • 12. MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines.
    Aygun N, Altungoz O.
    Mol Med Rep; 2019 Jan 16; 19(1):345-361. PubMed ID: 30483774
    [Abstract] [Full Text] [Related]

  • 13. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues.
    Misra DN, Dickman PS, Yunis EJ.
    Diagn Mol Pathol; 1995 Jun 16; 4(2):128-35. PubMed ID: 7551293
    [Abstract] [Full Text] [Related]

  • 14. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.
    Blumrich A, Zapatka M, Brueckner LM, Zheglo D, Schwab M, Savelyeva L.
    Hum Mol Genet; 2011 Apr 15; 20(8):1488-501. PubMed ID: 21258086
    [Abstract] [Full Text] [Related]

  • 15. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R.
    Oncogene; 1995 Apr 06; 10(7):1417-22. PubMed ID: 7731693
    [Abstract] [Full Text] [Related]

  • 16. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
    Valent A, Guillaud-Bataille M, Farra C, Lozach F, Spengler B, Terrier-Lacombe MJ, Valteau-Couanet D, Danglot G, Lenoir GM, Brison O, Bénard J, Bernheim A.
    Cancer Genet Cytogenet; 2004 Aug 06; 153(1):10-5. PubMed ID: 15325088
    [Abstract] [Full Text] [Related]

  • 17. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
    Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros P, Kovar H, Thoraval D, Elkahloun A, Meltzer P, Hanash SM.
    Med Pediatr Oncol; 2001 Jan 06; 36(1):75-9. PubMed ID: 11464910
    [Abstract] [Full Text] [Related]

  • 18. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
    Schwab M.
    Brain Pathol; 1990 Sep 06; 1(1):41-6. PubMed ID: 1669692
    [Abstract] [Full Text] [Related]

  • 19. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas.
    Hachitanda Y, Saito M, Mori T, Hamazaki M.
    Med Pediatr Oncol; 1997 Aug 06; 29(2):135-8. PubMed ID: 9180916
    [Abstract] [Full Text] [Related]

  • 20. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance?
    Ambros IM, Rumpler S, Luegmayr A, Hattinger CM, Strehl S, Kovar H, Gadner H, Ambros PF.
    Eur J Cancer; 1997 Oct 06; 33(12):2043-9. PubMed ID: 9516850
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.